Acquisition And Intellectual PropertyAcquisition of a company that develops integrated robotics and AI for tissue assessment strengthens the surgical robotics portfolio and appears to secure strategic control of the biopsy technology through a dedicated holding entity.
Imaging Technology AdvancementDye-free hyperspectral tissue oxygenation imaging that produces real-time quantitative maps could simplify workflow, reduce reliance on contrast agents, and improve surgical decision-making and training.
New Platform Product CycleLaunch of a new-generation surgical robot is expected to prompt hospitals to upgrade systems, expand robotic fleets, and drive broader procedure volume growth across the installed base.